Get the Stockscreener App
1.0901
8.39%
-0.0999
Oncolytics Biotech Inc stock is traded at $1.0901, with a volume of 1.04M.
It is down -8.39% in the last 24 hours and down -21.01% over the past month.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.
See More
Previous Close:
$1.19
Open:
$1.18
24h Volume:
1.04M
Relative Volume:
1.03
Market Cap:
$109.90M
Revenue:
-
Net Income/Loss:
$-20.31M
P/E Ratio:
-4.1214
EPS:
-0.2645
Net Cash Flow:
$-21.07M
1W Performance:
-9.91%
1M Performance:
-21.01%
6M Performance:
+98.20%
1Y Performance:
-7.62%
1-Day Range:
$1.08
$1.19
1-Week Range:
$1.08
$1.32
52-Week Range:
$0.3258
$1.51
Oncolytics Biotech Inc Stock (ONCY) Company Profile
Compare ONCY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ONCY
Oncolytics Biotech Inc
|
1.095 | 124.38M | 0 | -20.31M | -21.07M | -0.2645 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.69 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
641.80 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.61 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.11 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.82 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Oncolytics Biotech Inc Stock (ONCY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-13-25 | Initiated | Lake Street | Buy |
| Oct-06-22 | Initiated | Maxim Group | Buy |
| Feb-17-21 | Initiated | H.C. Wainwright | Buy |
Oncolytics Biotech Inc Stock (ONCY) Latest News
Can Oncolytics Biotech Inc. stock rebound after recent weaknessGlobal Markets & AI Enhanced Trading Alerts - newser.com
Why analysts remain bullish on Oncolytics Biotech Inc. stockJuly 2025 PreEarnings & Capital Efficient Trading Techniques - newser.com
How to interpret RSI for Oncolytics Biotech Inc. stockWeekly Trade Recap & Verified Swing Trading Watchlists - newser.com
Is Oncolytics Biotech Inc. stock gaining market shareMarket Rally & Verified Chart Pattern Signals - newser.com
Will Oncolytics Biotech Inc. outperform the marketMarket Weekly Review & AI Driven Price Predictions - newser.com
Combining price and volume data for Oncolytics Biotech Inc.Portfolio Performance Summary & Weekly Watchlist of Top Performers - newser.com
What recovery options are there for Oncolytics Biotech Inc.2025 Support & Resistance & Safe Swing Trade Setups - newser.com
Visual trend scoring systems applied to Oncolytics Biotech Inc.Jobs Report & Community Consensus Trade Signals - newser.com
What margin trends mean for Oncolytics Biotech Inc. stockJuly 2025 Recap & Free Technical Pattern Based Buy Signals - newser.com
Analyzing Oncolytics Biotech Inc. with risk reward ratio chartsJuly 2025 Drop Watch & Advanced Technical Signal Analysis - newser.com
Backtesting results for Oncolytics Biotech Inc. trading strategiesRisk Management & Precise Buy Zone Tips - newser.com
Heatmap analysis for Oncolytics Biotech Inc. and competitorsQuarterly Trade Report & Weekly Momentum Picks - newser.com
Will Oncolytics Biotech Inc. stock recover faster than peersMarket Risk Summary & Daily Entry Point Trade Alerts - newser.com
Identifying reversal signals in Oncolytics Biotech Inc.July 2025 Gainers & Weekly Return Optimization Alerts - newser.com
What is HC Wainwright's Estimate for ONCY Q1 Earnings? - MarketBeat
What dividend safety score for Oncolytics Biotech Inc. stockWeekly Trading Summary & Weekly Return Optimization Plans - newser.com
Is Oncolytics Biotech Inc. stock overvalued by current metricsJuly 2025 Analyst Calls & Community Verified Watchlist Alerts - newser.com
Can you recover from losses in Oncolytics Biotech Inc.Portfolio Value Report & Expert Approved Momentum Ideas - newser.com
What makes PLAY stock price move sharply - newser.com
Will Oncolytics Biotech Inc. stock reach Wall Street targets2025 Bull vs Bear & Smart Allocation Stock Reports - newser.com
Oncolytics Biotech Inc Stock (ONCY) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.27%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):